The detailed information for PTAB case with proceeding number PGR2023-00014 filed by Forte Biosciences, Inc. against University of Massachusetts et al. on Dec 22, 2022. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
PGR2023-00014
Filing Date
Dec 22, 2022
Petitioner
Forte Biosciences, Inc.
Respondent
University of Massachusetts et al.
Status
Final Written Decision - Appealed
Respondent Application Number
16608116
Respondent Tech Center
1600
Respondent Patent Number
11278505
Institution Decision Date
Jul 3, 2023
Termination Date
Jun 24, 2024

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Patent Owner's Notice of Appeal

Dec 30, 2024PAPERPATENT OWNER

Decision Denying Patent Owner’s Request for Rehearing

Oct 30, 2024PAPERBOARD

Patent Owner's Updated Mandatory Notices

Sep 5, 2024PAPERPATENT OWNER

Patent Owner's Request for Rehearing

Jul 24, 2024PAPERPATENT OWNER

Final Written Decision: original

Jun 24, 2024PAPERBOARD

Other: Hearing transcript

May 31, 2024PAPERBOARD

Patent Owner's Updated Mandatory Notices

Mar 29, 2024PAPERPATENT OWNER

LEAP Practitioner Request and Verification Form (Patent Owner)

Mar 14, 2024PAPERBOARD

Petitioner's Demonstratives

Mar 14, 2024PAPERPETITIONER

Patent Owner's Updated Exhibit List

Mar 14, 2024PAPERPATENT OWNER

Patent Owner Demonstratives

Mar 14, 2024EXHIBITPATENT OWNER

Patent Owner's Updated Mandatory Notices

Mar 13, 2024PAPERPATENT OWNER

Petitioner's Reply to Opposition to Motion to Exclude

Mar 13, 2024PAPERPETITIONER

Order: Granting Patent Owners Motion to Withdraw Counsel and Substitute New Counsel 37 C.F.R. sec. 42.10

Mar 8, 2024PAPERBOARD

Patent Owner's Opposition to Petitioner's Motion to Exclude

Mar 8, 2024PAPERPATENT OWNER

Patent Owner's Unopposed Motion for Withdrawal and Substitution of Counsel

Mar 6, 2024PAPERPATENT OWNER

Petitioner's Motion to Exclude Evidence

Mar 4, 2024PAPERPETITIONER

Patent Owner's Sur-Reply

Feb 28, 2024PAPERPATENT OWNER

Patent Owner's Updated Exhibit List

Feb 28, 2024PAPERPATENT OWNER

Plott Depo Transcript (Feb 23, 2024)

Feb 28, 2024EXHIBITPATENT OWNER

ORDER Setting Oral Argument 37 C.F.R. § 42.70

Feb 22, 2024PAPERBOARD

Patent Owner's Request for Oral Argument

Feb 9, 2024PAPERPATENT OWNER

Petitioner's Request for Oral Argument

Feb 9, 2024PAPERPETITIONER

Patent Owner's Notice of Deposition of Dr. R. Todd Plott

Jan 26, 2024PAPERPATENT OWNER

Notice of Stipulation to Modify Trial Due Dates 3, 5, and 6

Jan 24, 2024PAPERPATENT OWNER

Patent Owner's Objections to Petitioner's Reply Evidence

Jan 17, 2024PAPERPATENT OWNER

Petitioner's Reply to Patent Owner Response

Jan 9, 2024PAPERPETITIONER

“JAK Inhibition Prevents Bleomycin-Induced Fibrosis in Mice and is Effective in Patients with Morphea,” W. Damsky, et al., J. of Inventigative Dermatology, 2020(140): 1446-1449

Jan 9, 2024EXHIBITPETITIONER

Tweet from William Damsky MD, PhD., re Global Derm Talks, Sep. 22, 2020

Jan 9, 2024EXHIBITPETITIONER

“Global Dermatology Talks is a Virtual Lecture Series for Equitable Dissemination of Dermatologic Information”, S. Ederain, et al., JAAD Int., 2022(9):116-118

Jan 9, 2024EXHIBITPETITIONER

“Translational Research in Vitiligo; Launching a New Era of Targeted Treatments,” John E. Harris, MD, PhD, Global Dermatology Talks, Feb. 22, 2021

Jan 9, 2024EXHIBITPETITIONER

Tweet from William Damsky MD, PhD to Dr. Jill Richmond, PhD, Mar. 22, 2021

Jan 9, 2024EXHIBITPETITIONER

“Dramatic Responses in Cutaneous Sarcoiddosis With JAK Inhibitor, Charles Bankhead, MedPage Today (Nov. 7, 2021)

Jan 9, 2024EXHIBITPETITIONER

“JAK Inhibitors in Dermatology: What to Know About These “New” Kids on the Block”, William Damsky M.D. Ph.D., Medical Dermatology Society Annual Meeting (Mar. 24, 2022)

Jan 9, 2024EXHIBITPETITIONER

Tweet from William Damsky to John E. Harris, MD, PhD., re Skin of Color Society Meeting (Mar. 16, 2023)

Jan 9, 2024EXHIBITPETITIONER

“Dermatology Meeting News 2023: A Personalized Approach to Treating Inflammtory Skin Diseases,” William Damsky (Mar. 23, 2023)

Jan 9, 2024EXHIBITPETITIONER

Transcript of Nov. 20, 2023 Deposition of William Damsky, M.D., Ph.D

Jan 9, 2024EXHIBITPETITIONER

Reply Declaration of R. Todd Plott

Jan 9, 2024EXHIBITPETITIONER

“Update on IL-15 vitiligo treatment,” John E. Harris, UMass Chan Medical School Vitiligo Clinic & Research Center Vitiligo Blog, (Jan. 13, 2020), available at https://www.umassmed.edu/vitiligo/blog/blog-posts1/2020/01/update-on-il-15-vitiligo-treatment/ (last visited Dec. 5, 2023)

Jan 9, 2024EXHIBITPETITIONER

“Tareting Interluekin-15 in Patients with Rheumatoid Arthritis,” Bo Baslund et al., Arthritis & Rheumatism (2005) 52(9):2686-2692

Jan 9, 2024EXHIBITPETITIONER

ClinicalTrial.Gov Study Details for NCT00433875, Phase 2 AMG714 in Rheumatoid Arthritis, available at https://clinicaltrials.gov/study/NCT00433875?intr=AMG714&limit=100&rank=3 (last visited Dec. 5, 2023)

Jan 9, 2024EXHIBITPETITIONER

ClinicalTrial.Gov Study Details for NCT00443326, AMG714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects, available at https://clinicaltrials.gov/study/NCT00443326?intr=AMG714& limit=100&rank=1 (last visited Dec. 5, 2023)

Jan 9, 2024EXHIBITPETITIONER

Abstract of “Safety and efficacy of AMG714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study,” Marja-Leena Lahdeaho, et al., Lancet Gastroenterol. Hepatol. (2019) 4(12):948-959, available at https://pubmed.ncbi.nlm.nih.gov (last visited Dec. 5, 2023)

Jan 9, 2024EXHIBITPETITIONER

Abstract of “Safety and efficacy of AMG714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study,” Christophe Cellier, et al., Lancet Gastroenterol. Hepatol. (2019) 4(12):960-970, available at https://pubmed.ncbi.nlm.nih.gov (last visited Dec. 5, 2023)

Jan 9, 2024EXHIBITPETITIONER

“Identification of a potent anti-IL-15 antibody with opposing mechanisms of action in vitro and in vivo,” DK Finch, et al., British Journal of Pharmacology (2011) 162:480-490

Jan 9, 2024EXHIBITPETITIONER

ClinicalTrial.Gov Search Results for Hu-Mikb1, available at https://clinicaltrials.gov/search?intr=Hu MiK-Beta-1 (last visited Dec. 5, 2023)

Jan 9, 2024EXHIBITPETITIONER

“Diagnosing Vitiligo and Improving Care Provider Awareness,” Seemal Desai and William Damsky, DermView Innovations in the Treatment of Vitiligo: Episode 4 (Nov. 30, 2021), available at https://www.dermatologytimes.com/view/diagnosing-vitiligo-and-improving-care-provider-awareness (last visited Nov. 19. 2023)

Jan 9, 2024EXHIBITPETITIONER

“The pathogenesis of Vitiligo,” Neel Malhotra and Marlene Dytoc, J. Cutaneous Med. & Surgery (2013) 17(3):153-172

Jan 9, 2024EXHIBITPETITIONER

“A New Phenylpyrazoleanilide, Y-320, Inhibits Interluekin 17 Production and Ameliorates Collagen-Induced Arthritis in Mice and Cynomolgus Monkeys,” Ushio et al., Pharmaceuticals (2014) 7:1-17

Jan 9, 2024EXHIBITPETITIONER

Paragraph 70 of Damsky Declaration from Damsky Deposition

Jan 9, 2024EXHIBITPETITIONER

Order: Modification to Scheduling Order

Nov 14, 2023PAPERBOARD

Notice of Deposition of William Damsky, M.D., Ph.D.

Oct 31, 2023PAPERPETITIONER

Patent Owner's Updated Mandatory Notices

Oct 13, 2023PAPERPATENT OWNER

Petitioner's Objections to Evidence

Oct 11, 2023PAPERPETITIONER

Patent Owner's Response

Oct 3, 2023PAPERPATENT OWNER

Patent Owner's Updated Exhibit List

Oct 3, 2023PAPERPATENT OWNER

Abbas book

Oct 3, 2023EXHIBITPATENT OWNER

Forte press release

Oct 3, 2023EXHIBITPATENT OWNER

Forte investor presentation

Oct 3, 2023EXHIBITPATENT OWNER

Damsky Declaration

Oct 3, 2023EXHIBITPATENT OWNER

Damsky Curriculum Vitae

Oct 3, 2023EXHIBITPATENT OWNER

Abbas Depo Transcript

Oct 3, 2023EXHIBITPATENT OWNER

Plott Depo Transcript

Oct 3, 2023EXHIBITPATENT OWNER

EX1036 - Forte ROG Response

Oct 3, 2023EXHIBITPATENT OWNER

Fehniger 2001

Oct 3, 2023EXHIBITPATENT OWNER

Cheever 2008

Oct 3, 2023EXHIBITPATENT OWNER

Yokoyama 2009

Oct 3, 2023EXHIBITPATENT OWNER

WO 2014/191822 A1

Oct 3, 2023EXHIBITPATENT OWNER

WO 2014/191823 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 2016/0235762 A1

Oct 3, 2023EXHIBITPATENT OWNER

Ushio 2008

Oct 3, 2023EXHIBITPATENT OWNER

Ruchatz 1998

Oct 3, 2023EXHIBITPATENT OWNER

Kim 1998

Oct 3, 2023EXHIBITPATENT OWNER

US 7,736,638 B2

Oct 3, 2023EXHIBITPATENT OWNER

WO 2003/017935 A2

Oct 3, 2023EXHIBITPATENT OWNER

Epron 2012

Oct 3, 2023EXHIBITPATENT OWNER

Wilson & Arkin 2010

Oct 3, 2023EXHIBITPATENT OWNER

Liao 2013

Oct 3, 2023EXHIBITPATENT OWNER

WO 2015/181394 A1

Oct 3, 2023EXHIBITPATENT OWNER

WO 2015/044761 A1

Oct 3, 2023EXHIBITPATENT OWNER

Feldmann 2003

Oct 3, 2023EXHIBITPATENT OWNER

WO 2010/037818 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 10,202,433 B2

Oct 3, 2023EXHIBITPATENT OWNER

US 2002/0082230 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 5,985,663

Oct 3, 2023EXHIBITPATENT OWNER

US 7,153,507

Oct 3, 2023EXHIBITPATENT OWNER

US 9,133,244

Oct 3, 2023EXHIBITPATENT OWNER

Antonelli 2015

Oct 3, 2023EXHIBITPATENT OWNER

Sundberg 1994

Oct 3, 2023EXHIBITPATENT OWNER

Xing supplemental figures

Oct 3, 2023EXHIBITPATENT OWNER

Manga 2016

Oct 3, 2023EXHIBITPATENT OWNER

van den Boorn 2009

Oct 3, 2023EXHIBITPATENT OWNER

Cavalie 2015

Oct 3, 2023EXHIBITPATENT OWNER

Adachi 2015

Oct 3, 2023EXHIBITPATENT OWNER

Mackay 2013

Oct 3, 2023EXHIBITPATENT OWNER

US 2009/0123414 A1

Oct 3, 2023EXHIBITPATENT OWNER

Abbas 2018

Oct 3, 2023EXHIBITPATENT OWNER

US 6,468,798

Oct 3, 2023EXHIBITPATENT OWNER

Hamajima 1998

Oct 3, 2023EXHIBITPATENT OWNER

Forte Pipeline Website

Oct 3, 2023EXHIBITPATENT OWNER

Richmond 2018

Oct 3, 2023EXHIBITPATENT OWNER

US 5,591,630 A

Oct 3, 2023EXHIBITPATENT OWNER

US 9,428,573 B2

Oct 3, 2023EXHIBITPATENT OWNER

US 8,431,524 B2

Oct 3, 2023EXHIBITPATENT OWNER

WO 2000/002582 A2

Oct 3, 2023EXHIBITPATENT OWNER

US 8,163,879

Oct 3, 2023EXHIBITPATENT OWNER

Frisoli and Harris 2017

Oct 3, 2023EXHIBITPATENT OWNER

Rodrigues 2017

Oct 3, 2023EXHIBITPATENT OWNER

Rodrigues 2017b

Oct 3, 2023EXHIBITPATENT OWNER

Relke and Gooderham 2019

Oct 3, 2023EXHIBITPATENT OWNER

Dappled dilemma article

Oct 3, 2023EXHIBITPATENT OWNER

Birlea

Oct 3, 2023EXHIBITPATENT OWNER

Parsad 2013

Oct 3, 2023EXHIBITPATENT OWNER

Lei 2021

Oct 3, 2023EXHIBITPATENT OWNER

Rashighi and Harris 2017

Oct 3, 2023EXHIBITPATENT OWNER

Oh 2011

Oct 3, 2023EXHIBITPATENT OWNER

Regazzetti 2015

Oct 3, 2023EXHIBITPATENT OWNER

Stenn & Plass 2001

Oct 3, 2023EXHIBITPATENT OWNER

Harries 2010

Oct 3, 2023EXHIBITPATENT OWNER

Bertolini 2020

Oct 3, 2023EXHIBITPATENT OWNER

Purwar 2011

Oct 3, 2023EXHIBITPATENT OWNER

Rodriguez 2014

Oct 3, 2023EXHIBITPATENT OWNER

Liu 2016

Oct 3, 2023EXHIBITPATENT OWNER

Nilforoushzadeh 2012

Oct 3, 2023EXHIBITPATENT OWNER

Liu 2017

Oct 3, 2023EXHIBITPATENT OWNER

Blumberg 2012

Oct 3, 2023EXHIBITPATENT OWNER

van der Fits 2009

Oct 3, 2023EXHIBITPATENT OWNER

Braegelmann 2021

Oct 3, 2023EXHIBITPATENT OWNER

Abbas 2020

Oct 3, 2023EXHIBITPATENT OWNER

Chinen 2016

Oct 3, 2023EXHIBITPATENT OWNER

van den Hoogen 2011

Oct 3, 2023EXHIBITPATENT OWNER

Grabstein 1994

Oct 3, 2023EXHIBITPATENT OWNER

Budagian 2006

Oct 3, 2023EXHIBITPATENT OWNER

Robinson 2017

Oct 3, 2023EXHIBITPATENT OWNER

Chirifu 2007

Oct 3, 2023EXHIBITPATENT OWNER

Mishra 2014

Oct 3, 2023EXHIBITPATENT OWNER

Lu 2002

Oct 3, 2023EXHIBITPATENT OWNER

Wilson & Arkin 2010

Oct 3, 2023EXHIBITPATENT OWNER

US 10,301,384

Oct 3, 2023EXHIBITPATENT OWNER

US 5,844,099

Oct 3, 2023EXHIBITPATENT OWNER

US 2003/0013668

Oct 3, 2023EXHIBITPATENT OWNER

WO 2012/061536 A2

Oct 3, 2023EXHIBITPATENT OWNER

Bernard 2004

Oct 3, 2023EXHIBITPATENT OWNER

Nomeir 2000

Oct 3, 2023EXHIBITPATENT OWNER

Frankel 2014

Oct 3, 2023EXHIBITPATENT OWNER

Moy 2007

Oct 3, 2023EXHIBITPATENT OWNER

Shi 2002

Oct 3, 2023EXHIBITPATENT OWNER

West 1992

Oct 3, 2023EXHIBITPATENT OWNER

Regazzetti 2015

Oct 3, 2023EXHIBITPATENT OWNER

Discovery Request

Oct 3, 2023EXHIBITPATENT OWNER

Rashighi 2015

Oct 3, 2023EXHIBITPATENT OWNER

Riding 2019

Oct 3, 2023EXHIBITPATENT OWNER

Grimes 2005

Oct 3, 2023EXHIBITPATENT OWNER

Incyte Press Release

Oct 3, 2023EXHIBITPATENT OWNER

WO 2017/046200 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 7,858,081 B2

Oct 3, 2023EXHIBITPATENT OWNER

US 6,001,973 A

Oct 3, 2023EXHIBITPATENT OWNER

US 5,795,966 A

Oct 3, 2023EXHIBITPATENT OWNER

US 2017/0101452 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 2006/0236411 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 2006/0057680 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 2005/0123542 A1

Oct 3, 2023EXHIBITPATENT OWNER

US 10,150,802 B2

Oct 3, 2023EXHIBITPATENT OWNER

US 7,579,439 B2

Oct 3, 2023EXHIBITPATENT OWNER

US 6,087,172 A

Oct 3, 2023EXHIBITPATENT OWNER

Mortier 2006

Oct 3, 2023EXHIBITPATENT OWNER

Ferrari-Lacraz 2004

Oct 3, 2023EXHIBITPATENT OWNER

Forte - May 11 2023 Report

Oct 3, 2023EXHIBITPATENT OWNER

Patent Owner's Updated Mandatory Notices

Sep 25, 2023PAPERPATENT OWNER

Order: Conduct of the Proceeding 37 C.F.R. §§ 42.51(b)(2) Granting Patent Owner’s Motion to Withdraw 37 C.F.R. § 42.10(e)

Sep 19, 2023PAPERBOARD

Patent Owner's Notice of Deposition of Dr. Abul K. Abbas

Aug 25, 2023PAPERPATENT OWNER

Patent Owner's Notice of Deposition of Dr. R. Todd Plott

Aug 25, 2023PAPERPATENT OWNER

Patent Owner's Unopposed Motion for Withdrawal of Counsel

Jul 27, 2023PAPERPATENT OWNER

Notice of Stipulation to Modify Trial Due Dates 1-3

Jul 26, 2023PAPERPATENT OWNER

Patent Owner's Objections to Petitioner's Exhibits

Jul 18, 2023PAPERPATENT OWNER

Institution Decision: Grant

Jul 3, 2023PAPERBOARD

Order: Scheduling Order

Jul 3, 2023PAPERBOARD

Patent Owner's Unopposed Motion for Withdrawal of Counsel

Jun 21, 2023PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notices

Jun 21, 2023PAPERPATENT OWNER

Patent Owner's Preliminary Response

Apr 10, 2023PAPERPATENT OWNER

Harris 2015

Apr 10, 2023EXHIBITPATENT OWNER

Patent Owner's Exhibit List

Apr 10, 2023PAPERPATENT OWNER

Notice : Mandatory Notice

Jan 12, 2023PAPERPATENT OWNER

Notice : Power of Attorney

Jan 12, 2023PAPERPATENT OWNER

Notice: Notice filing date accorded

Jan 11, 2023PAPERBOARD

U.S. Patent No. 11,278,505 to Richmond et al.

Dec 22, 2022EXHIBITPETITIONER

Harris 2012 “A Mouse Model of Vitiligo ...

Dec 22, 2022EXHIBITPETITIONER

Xing “Alopecia areata is driven by cytotoxic T lymphocytes

Dec 22, 2022EXHIBITPETITIONER

International Publication No. WO 2009/002562 to Pavlakis et al.

Dec 22, 2022EXHIBITPETITIONER

Part 1 - File History for Application No. 16/608,116

Dec 22, 2022EXHIBITPETITIONER

Part 2 - File History for Application No. 16/608,116

Dec 22, 2022EXHIBITPETITIONER

Part 3 - File History for Application No. 16/608,116

Dec 22, 2022EXHIBITPETITIONER

U.S. Patent No. 9,028,830 to Tso et al.

Dec 22, 2022EXHIBITPETITIONER

Waldman 2013 - Phase 1 trial of IL-15 trans presentation

Dec 22, 2022EXHIBITPETITIONER

DeGottardi et al., "Effect of anti-IL-15 administration on T cell

Dec 22, 2022EXHIBITPETITIONER

B. Jabri 2015 , “IL‑15 functions as a danger signal to regulate

Dec 22, 2022EXHIBITPETITIONER

Waldman 2006, “The biology of interleukin-2 and interleukin-15:

Dec 22, 2022EXHIBITPETITIONER

MacKay et. al 2015, T-box Transcription Factors Combine with the Cytokines

Dec 22, 2022EXHIBITPETITIONER

Villadsen 2003, “Resolution of psoriasis upon blockade of IL-15

Dec 22, 2022EXHIBITPETITIONER

Rork 2016, “Understanding autoimmunity of vitiligo and alopecia areata,

Dec 22, 2022EXHIBITPETITIONER

Rashighi 2014, CXCL10 Is Critical for the Progression and Maintenance of

Dec 22, 2022EXHIBITPETITIONER

Damsky et al., “JAK inhibitors in dermatology: The promise of a new drug

Dec 22, 2022EXHIBITPETITIONER

Waldman 2004, “Targeting the interleukin-15/interleukin-15 receptor system

Dec 22, 2022EXHIBITPETITIONER

P. Agarwal 2015, “Simvastatin prevents and reverses depigmentation in

Dec 22, 2022EXHIBITPETITIONER

Kennedy 2000, “Reversible Defects in Natural Killer and Memory CD8 T Cell

Dec 22, 2022EXHIBITPETITIONER

Becker 2002, “Interleukin 15 is required for proliferative renewal of virus

Dec 22, 2022EXHIBITPETITIONER

Cheuk 2017, “CD49a Expression Defines Tissue-Resident CD8+ T Cells

Dec 22, 2022EXHIBITPETITIONER

Hechinger 2015, “Therapeutic activity of multiple common γ-chain cytokine

Dec 22, 2022EXHIBITPETITIONER

Gilhar 2016, “Alopecia areata: Animal models illuminate autoimmune

Dec 22, 2022EXHIBITPETITIONER

Craiglow 2015, “Tofacitinib Citrate for the Treatment of Vitiligo: A Patho

Dec 22, 2022EXHIBITPETITIONER

Gilhar 2013, “Autoimmune disease induction in a healthy human organ:

Dec 22, 2022EXHIBITPETITIONER

John E. Harris “Vitiligo and alopecia areata: apples and oranges?,”

Dec 22, 2022EXHIBITPETITIONER

C.M. Roifman "Human IL-2 Receptor α Chain Deficiency

Dec 22, 2022EXHIBITPETITIONER

A. Aoyama 2012, “Low-dose IL-2 for In vivo expansion of CD4+ and CD8+

Dec 22, 2022EXHIBITPETITIONER

Harris 2016, “Rapid skin repigmentation on oral Ruxolitinib in a patient

Dec 22, 2022EXHIBITPETITIONER

Curriculum Vitae of Dr. R. Todd Plott

Dec 22, 2022EXHIBITPETITIONER

Declaration of Dr. R. Todd Plott

Dec 22, 2022EXHIBITPETITIONER

Declaration of Dr. Abul Abbas

Dec 22, 2022EXHIBITPETITIONER

Curriculum Vitae of Dr. Abul Abbas

Dec 22, 2022EXHIBITPETITIONER

Petitioner's Power of Attorney

Dec 22, 2022PAPERPETITIONER

Petition For Post-Grant Review

Dec 22, 2022PAPERPETITIONER